Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|4|529-535

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.4, 2014-02, pp. : 529-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2773-2785

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. : 1503-1517

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 9, 2011-09 ,pp. : 1343-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6215-6219

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease

By  

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2555-2571

Bentham Science Publishers

Access to resources Recommend Favorite